Improved survival at the population level for patients with advanced Merkel cell carcinoma following availability of immunotherapy
Published: 28 February 2025| Version 1 | DOI: 10.17632/d9ngfbjxp3.1
Contributors:
, , , , Description
Supplemental figure 1 relative survival by year of diagnosis and extent of MCC at presentation. Supplemental figure 2 24-month overall survival by year of diagnosis and extent of Merkel cell carcinoma at presentation.
Files
Institutions
University of Washington, Swedish Cancer Institute, Fred Hutchinson Cancer Research Center, Washington State University
Categories
Epidemiology, Oncology, Merkel Cell Carcinoma, Survival Analysis, Immunotherapy, Database
Funding
National Institutes of Health
P01 CA225517
National Institutes of Health
P30 CA015704
Prostate Cancer Foundation
Kelsey Dickson Team Science Courage Research Award
University of Washington
MCC Gift Fund
Washington State University
Paul G. Allen Research Center at Swedish Cancer Institute, Swedish Cancer Institute Foundation